Ocular Therapeutix (OCUL) Shares Outstanding (2013 - 2026)

Ocular Therapeutix (OCUL) Shares Outstanding (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Ocular Therapeutix 1.91 Bn 1.91 Bn 9.46 Mn 224.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 224.10 Mn
Dec 31, 2025 187.24 Mn
Sep 30, 2025 183.92 Mn
Jun 30, 2025 172.59 Mn
Mar 31, 2025 169.40 Mn
Dec 31, 2024 158.27 Mn
Sep 30, 2024 166.99 Mn
Jun 30, 2024 165.82 Mn
Mar 31, 2024 132.02 Mn
Dec 31, 2023 79.83 Mn
Sep 30, 2023 79.37 Mn
Jun 30, 2023 78.05 Mn
Mar 31, 2023 77.39 Mn
Dec 31, 2022 76.88 Mn
Sep 30, 2022 76.98 Mn
Jun 30, 2022 76.76 Mn
Mar 31, 2022 76.75 Mn
Dec 31, 2021 76.39 Mn
Sep 30, 2021 76.55 Mn
Jun 30, 2021 76.32 Mn